1Department of Clinical Microbiology and Microbial Pathogenesis, University Hospital of Heraklion, 71500 Crete, Greece.
2Department of Pediatrics, Agios Nikolaos General Hospital, Agios Nikolaos, 72100 Crete, Greece.
Acta Microbiol Immunol Hung. 2024 Feb 12;71(1):69-75. doi: 10.1556/030.2024.02214. Print 2024 Mar 26.
Diarrheal diseases are of great concern worldwide and are responsible for considerable morbidity and mortality. This study investigated the epidemiology and the antibiotic susceptibility of bacterial enteropathogens among diarrheal patients of all ages in Crete, Greece during 2011-2022. Stool specimens were tested by conventional cultural methods for Salmonella, Shigella, Campylobacter, diarrheagenic Escherichia coli (EPEC, STEC), Yersinia enterocolitica, Aeromonas species and Clostridioides difficile. Antimicrobial susceptibility was determined by the disk diffusion method for Enterobacterales, Campylobacter and Aeromonas, and by the gradient diffusion method for C. difficile. Of the 26,060 stool samples from patients of any age, 1,022 (3.9%) were positive for bacterial enteropathogens. Campylobacter spp. were the most commonly isolated bacteria (56.4%), followed by Salmonella enterica (32.3%), and E. coli (EPEC, STEC) (6.5%). Toxigenic C. difficile was isolated from 341 out of 8,848 diarrheal specimens examined (3.9%). Resistance to ampicillin was observed in 12.4% of Salmonella, 66.7% of Shigella and 34.8% of E. coli (EPEC, STEC) isolates. Resistance to trimethoprim/sulfamethoxazole was observed in 5.8% of Salmonella, 33.3% of Shigella, and 15.1% of E. coli (EPEC, STEC) isolates. High rates of ciprofloxacin resistance (77.3%) were detected among Campylobacter isolates, while resistance to erythromycin was observed in 2.4% of them. All C. difficile isolates were susceptible to vancomycin and metronidazole. Our findings suggest declining trends in prevalence of bacterial enteropathogens, except for Campylobacter spp. and changes in the susceptibility rates to antimicrobials. Continuous surveillance of prevalence and antimicrobial susceptibility of bacterial enteropathogens is mandatory for implementing targeted and effective prevention and infection control measures.
腹泻病是全球关注的重大问题,可导致较高的发病率和死亡率。本研究调查了 2011 年至 2022 年期间希腊克里特岛所有年龄段腹泻患者中细菌肠道病原体的流行病学和抗生素药敏情况。通过常规培养方法检测粪便标本中的沙门氏菌、志贺氏菌、弯曲杆菌、致泻性大肠埃希菌(EPEC、STEC)、耶尔森氏菌、气单胞菌属和艰难梭菌。通过纸片扩散法检测肠杆菌科、弯曲杆菌和气单胞菌的药敏情况,通过梯度扩散法检测艰难梭菌的药敏情况。在来自任何年龄患者的 26060 份粪便样本中,有 1022 份(3.9%)细菌肠道病原体检测阳性。弯曲杆菌属是最常见的分离菌(56.4%),其次是沙门氏菌(32.3%)和大肠埃希菌(EPEC、STEC)(6.5%)。在 8848 份腹泻标本中分离出 341 株产毒艰难梭菌(3.9%)。沙门氏菌的氨苄西林耐药率为 12.4%,志贺氏菌为 66.7%,EPEC、STEC 为 34.8%。沙门氏菌、志贺氏菌和 EPEC、STEC 的耐药率分别为 5.8%、33.3%和 15.1%。环丙沙星耐药率(77.3%)在弯曲杆菌属中较高,而红霉素耐药率为 2.4%。所有艰难梭菌均对万古霉素和甲硝唑敏感。本研究结果表明,除弯曲杆菌属外,细菌肠道病原体的流行率呈下降趋势,对抗生素的药敏率也发生了变化。必须对细菌肠道病原体的流行率和药敏率进行持续监测,以实施有针对性和有效的预防和感染控制措施。